Impact of comprehensive cardiovascular risk reduction programme on risk factor clustering associated with elevated blood pressure in an Indian industrial population

被引:0
|
作者
Jeemon, Panniyammakal [2 ,13 ]
Prabhakaran, Dorairaj [1 ,3 ,13 ]
Goenka, Shifalika [13 ]
Ramakrishnan, Lakshmy [4 ]
Padmanabhan, Sandosh [2 ]
Huffman, Mark [5 ]
Joshi, Prashant [6 ]
Sivasankaran, Sivasubramonian [7 ]
Mohan, B. V. M. [8 ]
Ahmed, F. [9 ]
Ramanathan, Meera [11 ]
Ahuja, R. [10 ]
Sinha, Nakul [12 ]
Thankappan, K. R. [7 ]
Reddy, K. S. [13 ]
机构
[1] Ctr Chron Dis Control, Safdarjung Dev Area, New Delhi 110016, India
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[3] Ctr Cardiometab Risk Reduct S Asia, Ctr Excellence, New Delhi, India
[4] All India Inst Med Sci, New Delhi, India
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Indira Gandhi Govt Med Coll, Nagpur, Maharashtra, India
[7] Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India
[8] Narayana Hrudayalaya Inst Med Sci, Bangalore, Karnataka, India
[9] KPC Med Coll, Kolkata, India
[10] King George Med Coll, Lucknow, Uttar Pradesh, India
[11] PSGIMSR Med Coll, Coimbatore, Tamil Nadu, India
[12] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India
[13] Publ Hlth Fdn India, New Delhi, India
基金
英国惠康基金;
关键词
Cardiovascular diseases; clustering; risk factors; risk reduction; INSULIN-RESISTANCE; DISEASE; STRATIFICATION; BURDEN; PREHYPERTENSION; HYPERTENSION; DIAGNOSIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Cardiovascular risk factors clustering associated with blood pressure (BP) has not been studied in the Indian population. This study was aimed at assessing the clustering effect of cardiovascular risk factors with suboptimal BP in Indian population as also the impact of risk reduction interventions. Methods: Data from 10543 individuals collected in a nation-wide surveillance programme in India were analysed. The burden of risk factors clustering with blood pressure and coronary heart disease (CHD) was assessed. The impact of a risk reduction programmme on risk factors clustering was prospectively studied in a sub-group. Results: Mean age of participants was 40.9 +/- 11.0 yr. A significant linear increase in number of risk factors with increasing blood pressure, irrespective of stratifying using different risk factor thresholds was observed. While hypertension occurred in isolation in 2.6 per cent of the total population, co-existence of hypertension and > 3 risk factors was observed in 12.3 per cent population. A comprehensive risk reduction programme significantly reduced the mean number of additional risk factors in the intervention population across the blood pressure groups, while continued to be high in the control arm without interventions (both within group and between group P < 0.001). The proportion of 'low risk phenotype' increased from 13.4 to 19.9 per cent in the intervention population and it was decreased from 27.8 to 10.6 per cent in the control population (P < 0.001). The proportion of individuals with hypertension and three more risk factors decreased from 10.6 to 4.7 per cent in the intervention arm while it was increased from 113.3 to 17.8 per cent in the control arm (P < 0.001). Interpretation & conclusions: Our findings showed that cardiovascular risk factors clustered together with elevated blood pressure and a risk reduction programme significantly reduced the risk factors burden.
引用
收藏
页码:485 / 493
页数:9
相关论文
共 50 条
  • [31] Risk Factors in Adolescence for the Development of Elevated Blood Pressure and Hypertension in American Indian and Alaskan Native Adults
    Zamora-Kapoor, Anna
    Hebert, Luciana E.
    Montanez, Morgan
    Buchwald, Dedra
    Sinclair, Ka'imi
    JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2021, 23 (04) : 717 - 724
  • [32] Prevalence and Risk Factors of Elevated Blood Pressure and Elevated Blood Glucose among Residents of Kajiado County, Kenya: A Population-Based Cross-Sectional Survey
    Ongosi, Anita Nyaboke
    Wilunda, Calistus
    Musumari, Patou Masika
    Techasrivichien, Teeranee
    Wang, Chia-Wen
    Ono-Kihara, Masako
    Serrem, Charlotte
    Kihara, Masahiro
    Nakayama, Takeo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (19) : 1 - 22
  • [33] Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women
    Preston, R. A.
    CLIMACTERIC, 2007, 10 : 32 - 41
  • [34] Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan
    Barrios, Vivencio
    Escobar, Carlos
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (09) : 1549 - 1558
  • [35] Predicting future cardiovascular risk from blood pressure response to dynamic exercise: a neglected risk factor?
    Stolarz-Skrzypek, Katarzyna
    Czarnecka, Danuta
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (12): : 850 - 851
  • [36] Ambulatory blood pressure monitoring and risk of cardiovascular disease: A population based study
    Hansen, TW
    Jeppesen, J
    Rasmussen, S
    Ibsen, H
    Torp-Pedersen, C
    AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (03) : 243 - 250
  • [37] Angiotensin II blockade and total cardiovascular risk: Beyond blood pressure reduction
    Cipollone F.
    Di Fabio S.
    Bucci M.
    Cicolini G.
    Mezzetti A.
    High Blood Pressure & Cardiovascular Prevention, 2008, 15 (4) : 245 - 253
  • [38] Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study
    Mori, Yuichiro
    Mizuno, Atsushi
    Fukuma, Shingo
    HYPERTENSION RESEARCH, 2024, 47 (06) : 1546 - 1554
  • [39] Adult Patients with Congenital Adrenal Hyperplasia Have Elevated Blood Pressure but Otherwise a Normal Cardiovascular Risk Profile
    Mooij, Christiaan F.
    Kroese, Jeanne Margot
    Sweep, Fred C. G. J.
    Hermus, Ad R. M. M.
    Tack, Cees J.
    PLOS ONE, 2011, 6 (09):
  • [40] Anxiety associated with a reduction of cardiovascular mortality risk in primary care population in Latvia
    Ivanovs, R.
    Kivite, A.
    Mintale, I.
    Vrublevska, J.
    Berze, L.
    Logins, R.
    Rancans, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S992 - S993